CYP2D6*102 | United Arab Emirates | NC_000022.11:g.42129821G>A(;)42127941G>A(;)42126611C>G | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.5990C>T(;)7870C>T(;)9200G>C; NM_000106.6:c.269C>T(;)886C>T(;)1457G>C | 267608309 16947 1135840 | |
CYP2D6*103 | United Arab Emirates | NC_000022.11:g.42126611C>G(;)42127941G>A(;)42129042T>C(;)42129821G>A | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.5990C>T(;)6769A>G(;)7870C>T(;)9200G>C; NM_000106.6:c.269C>T(;)496A>G(;)886C>T(;)1457G>C | 267608309 1135824 16947 1135840 | |
CYP2D6*104 | United Arab Emirates | NC_000022.11:g.42126611C>G(;)42127941G>A(;)42129071T>A | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.6740A>T(;)7870C>T(;)9200G>C; NM_000106.6:c.467A>T(;)886C>T(;)1457G>C | 16947 1135840 | |
CYP2D6*105 | United Arab Emirates | NC_000022.11:g.42126611C>G(;)42127523A>G(;)42127941G>A | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.7870C>T(;)8288T>C(;)9200G>C; NM_000106.6:c.886C>T(;)1097T>C(;)1457G>C | 16947 1555888910 1135840 | |
CYP2D6*17 | United Arab Emirates | NC_000022.11:g.42126611C>G(;) 42127941G>A(;)42129770G>A | Drug Response | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:6041C>T(;)7870C>T(;)9200G>C; NM_000106.6:c.NM_000106.6:c.320C>T(;)886C>T (;)1457G>C | 28371706 16947 1135840 | 830235 |
CYP2D6*2 | United Arab Emirates | NC_000022.11:g.42126611C>G(;)42127941G>A | Drug Response | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.7870C>T(;)9200G>C; NM_000106.6:c.886C>T(;)1457G>C | 16947 1135840 | 16895 |
CYP2D6*27 | United Arab Emirates | NC_000022.11:g.42126938C>T | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.8873G>A; NM_000106.6:c.1228G>A; NP_000097.3:p.Glu410Lys
| 769157652 | |
CYP2D6*29 | United Arab Emirates | NC_000022.11:g.42126611C>G(;)42127608C>T(;)42127941G>A(;)42129130C>G(;)42129132C>T | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.6679G>A(;)6681G>C(;)7870C>T(;)8203G>A(;)9200G>C; NM_000106.6:c.406G>A(;)408G>C(;)886C>T(;)1012G>A(;)1457G>C | 61736512 1058164 16947 59421388 1135840 | |
CYP2D6*35 | United Arab Emirates | NC_000022.11:g.42130761C>T(;)42127941G>A(;)42126611C>G | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.5050G>A(;)7870C>T(;)9200G>C; NM_000106.6:c.31G>A (;)886C>T(;)1457G>C | 769258 16947 1135840 | |
CYP2D6*4 | Lebanon; United Arab E... | NC_000022.11:g.42128945C>T | Drug Response | Drug Response | Breast Cancer; Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.6866G>A; NM_000106.6:c.506-1G>A; NP_000097.3:p.? | 3892097 | 16889 |
CYP2D6*41 | Lebanon; United Arab E... | NC_000022.11:g.42127803C>T | Drug Response, Likely Benign | Drug Response | Breast Cancer; Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.8008G>A; NM_000106.6:c.985+39G>A | 28371725 | 39381 |
CYP2D6*43 | United Arab Emirates | NC_000022.11:g.42130715C>T | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.4277G>A; NM_000106.5:c.77G>A; NP_000097.3:p.Arg26His | 28371696 | |
CYP2D6*46 | United Arab Emirates | NC_000022.11:g.42126611C>G(;)42127941G>A(;)42129075C>T(;)42130715C>T | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.5096G>A(;)6736G>A(;)7870C>T(;)9200G>C; NM_000106.6:c.77G>A(;)463G>A(;)886C>T(;)1457G>C | 28371696 28371710 16947 1135840 | |
NC_000022.11:g.42132969C>T | Lebanon | NC_000022.11:g.42132969C>T | | Drug Response | Breast Cancer | NG_008376.3:g.2023G>A | 28360521 | |
NM_000106.5:c.281A>G | United Arab Emirates | NC_000022.11:g.42129809T>C | Drug Response | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.5183A>G; NM_000106.5:c.281A>G; NP_000097.3:p.His94Arg | 28371704 | 829654 |
NM_000106.5:c.496A>G | United Arab Emirates | NC_000022.11:g.42129042T>C | Likely Benign | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.5950A>G; NM_000106.5:c.496A>G; NP_000097.3:p.Asn166Asp | 1135824 | 675907 |
NM_000106.5:c.886C>T | United Arab Emirates | NC_000022.11:g.42127941G>A | Benign | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.7051C>T; NM_000106.5:c.886C>T; NP_000097.3:p.Arg296Cys | 16947 | 242771 |
NM_000106.6:c.100C>T | Lebanon; United Arab E... | NC_000022.11:g.42130692G>A | Drug Response, Likely Benign | Drug Response | Breast Cancer; Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.5119C>T; NM_000106.6:c.100C>T; NP_000097.3:p.Pro34Ser | 1065852 | 16893 |
NM_000106.6:c.1012G>A | United Arab Emirates | NC_000022.11:g.42127608C>T | Likely Benign | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.7384G>A; NM_000106.6:c.1012G>A; NP_000097.3:p.Val338Met | 59421388 | 598263 |
NM_000106.6:c.1316-11C>A | United Arab Emirates | NC_000022.11:g.42126763G>T | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.9048C>A; NM_000106.6:c.1316-11C>A | 548264542 | |
NM_000106.6:c.1457G>C | United Arab Emirates | NC_000022.11:g.42126611C>G | Drug Response | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.4:g.9200G>C; NM_000106.6:c.1457G>C; NP_000097.3:p.Ser486Thr | 1135840 | 242701 |
NM_000106.6:c.505+25A>C | United Arab Emirates | NC_000022.11:g.42129008T>G | | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.5984A>C; NM_000106.6:c.505+25A>C; NP_000097.3:p.? | 200002499 | |
NM_000106.6:c.832G>A | United Arab Emirates | NC_000022.11:g.42128185C>T | Drug Response | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.6807G>A; NM_000106.6:c.832G>A; NP_000097.3:p.Glu278Lys | 77913725 | 828886 |
NM_000106.6:c.836T>A | United Arab Emirates | NC_000022.11:g.42128181A>T | Drug Response | Drug Response | Drug Metabolism, Poor, CYP2D6-Related | NG_008376.3:g.6811T>A; NM_000106.6:c.836T>A; NP_000097.3:p.Met279Lys | 1135828 | 828887 |